Clinical Trials Logo

Clinical Trial Summary

This study aims to establish abbreviated PB MRI protocol for patients on regular imaging follow-up for pancreas cystic neoplasm.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03731819
Study type Interventional
Source Seoul National University Hospital
Contact
Status Completed
Phase N/A
Start date November 5, 2018
Completion date May 4, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04970056 - Pancreatic Cancer Early Detection Consortium
Recruiting NCT05155878 - Prognostic Factors in Periampullary Tumors and Cysts
Recruiting NCT03536793 - Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
Completed NCT06227871 - A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes
Recruiting NCT03855800 - Molecular Detection of Advanced Neoplasia in Pancreatic Cysts N/A
Recruiting NCT05714111 - Radiology Registry on Pancreatic Malignancies
Recruiting NCT04104230 - Quebec Pancreas Cancer Study
Recruiting NCT03568630 - Blood Markers of Early Pancreas Cancer
Active, not recruiting NCT04200131 - Moray Micro Forceps and Pancreatic Cyst N/A
Active, not recruiting NCT03305146 - Feasibility of Molecular Biology in Pancreatic Cyst Tumors N/A
Completed NCT03820531 - DNA-mutation Analysis in Cyst Fluid of Suspected Intraductal Papillary Mucinous Neoplasia of the Pancreas N/A
Recruiting NCT06055010 - Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
Recruiting NCT04324294 - Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions Phase 1
Completed NCT03172572 - A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers
Completed NCT01807325 - RNA Sequencing of Solid and Cystic Lesions of the Pancreas
Completed NCT04064034 - ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer N/A